-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Pliant Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2019 to 2024.
- Pliant Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$30.3M, a 0.02% increase year-over-year.
- Pliant Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$156M, a 33.6% decline from 2023.
- Pliant Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$116M, a 23% decline from 2022.
- Pliant Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$94.6M, a 25.4% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)